Onego Bio Opens San Diego Office With Focus on Scaling U.S. Commercial Capabilities

San Diego, CA – September 25, 2024 – Onego Bio, a leading US-Finnish foodtech company, is proud to announce the opening of its new San Diego office. The 5,000-square-foot facility will serve as the company’s U.S. commercial headquarters, housing office space alongside cutting-edge lab facilities and a state-of-the-art test kitchen. The facility will serve as a resource for food manufacturing partners, where Onego Bio will work collaboratively to showcase the versatility and capabilities of its ingredient Bioalbumen®—a breakthrough animal-free egg protein powder that mirrors the taste, nutrition, and functionality of traditional eggs while boasting an environmental footprint that’s over 90% smaller.

Onego's co-founders Maija and Chris officially opening the San Diego office

“The test kitchen will demonstrate Bioalbumen®'s application in a variety of food categories, including pasta, bakery, and confections,” said Maija Itkonen, CEO & Co-found of Onego Bio. “By leveraging precision fermentation technology, we are addressing the global demand for egg protein at scale, helping to create resilient supply chains and power a more sustainable food system.”

With over $70 million in funding to date, Onego Bio has established the US as its commercial epicenter, with the opening of its San Diego office marking a significant milestone in the company’s growth. San Diego’s reputation as a biotechnology hub, combined with its proximity to world-class universities, research institutions, and a thriving network of food-tech innovators, makes it an ideal location for Onego Bio’s plans. The city's focus on sustainability and forward-thinking technology aligns seamlessly with Onego Bio’s vision of a more resilient, environmentally friendly food system.

"The opening of our San Diego office is a critical step forward in our journey to scale sustainable protein production," said Itkonen. “The city’s thriving biotech ecosystem, access to top-tier talent, and strong culture of innovation make it the perfect place for us to grow our US presence and collaborate with industry leaders.”

Onego is currently scaling up production of Bioalbumen® with co-manufacturers while finalizing plans for its first own industrial scale manufacturing unit in the US. The company employs a patented fungal fermentation technology that is highly scalable and enabling competitive costs compared to conventional egg protein production methods. A single Onego full-scale manufacturing unit will boast a two-million-liter fermentation capacity, effectively delivering the protein equivalent produced by six million laying hens.

For media inquiries please contact:

Laura Eriksson
Head of Brand & Communications
laura.eriksson@onego.bio

About Onego Bio

Onego Bio is a US-Finnish food tech company on a mission to build a more resilient food system with sustainable protein production. Through leveraging precision fermentation, Onego Bio produces Bioalbumen®—an non-animal egg protein that perfectly matches the taste, nutrition, and functionality of traditional eggs, with an environmental footprint that is over 90% smaller. Onego’s highly scalable technology paves the path for a global food industry that is less reliant on animal-derived proteins at an industrial scale, while catering to the industry’s growing demand for reliable and price-stable proteins. As a recognized leader in food innovation, Onego Bio was honored as the Winner of Fast Company’s 2023 World Changing Ideas awards and is a proud co-founder of the Precision Fermentation Alliance and Food Fermentation Europe.

Learn more at www.onego.bio.